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Substance-use disorders are a major global public health concern. 
The recent South African stress and health study (SASH) indicated 
a high lifetime prevalence (13.3%) and early onset (21 years) of 
such disorders,1 with significantly higher rates in the Western 
Cape compared with other provinces. Substance-abuse treatment 
services are limited in the Western Cape, where existing services are 
overwhelmed by the demand for treatment.2 
Increasing the range of treatment services is one way of improving 
access.2 The existing system relies heavily on provision of high-
threshold treatment services by specialist providers; few low-
threshold early-intervention services are available at a primary 
healthcare level. This limits access to care as high-threshold services 
are costly. More cost-effective lower threshold services are preferable. 
Evidence suggests that screening, brief intervention, and referral 
to treatment (SBIRT) is effective for addressing mild to moderate 
substance-related problems and is feasible to implement.3,4 However, 
there is little evidence for the effectiveness or feasibility of SBIRT for 
substance use in South Africa. We describe preliminary outcomes 
from a hospital-based SBIRT programme. 
Methods
The SBIRT programme emerged from the realisation that substance-
related psychoses were observed in more than 80% of the 250 monthly 
patients seeking psychiatric services in G F Jooste Hospital (David 
Fourie, personal communication). A substance-abuse intervention 
model was developed by SANCA Western Cape, the Department of 
Social Development, the Department of Health and Cape Town Drug 
Counselling Centre. Implementation of the model saw the initiation 
of a substance-abuse services centre at the hospital, staffed by a social 
worker, an auxiliary social worker and a research assistant.
Over a 7-month period, patients referred to the centre were given 
verbal and written information about the programme. A modified 
version of the alcohol, smoking and substance involvement screening 
test (ASSIST) was used to screen patients for substance use.5 Patients 
were categorised as low-, moderate- or high-risk depending on the 
severity of substance use. Patient sociodemographic information 
was collected. Immediately following screening, patients received 
a brief intervention (based on motivational interviewing) from 
the social worker. Motivational interviewing provides information 
or advice, motivates a change in substance use and teaches 
skills to reduce substance use by behavioural change.4 High-risk 
participants were referred to specialist substance-abuse treatment 
centres following intervention, as they were more likely to have 
substance dependence or related health conditions.5
An uncontrolled one-group pre- and post-test outcomes evaluation 
was performed by an independent external evaluator. All enrolled 
participants were evaluated. At the 3-month follow-up, the ASSIST 
was re-administered to all patients and a feedback questionnaire was 
completed.
Outcomes
Primary outcome: substance use 
The ASSIST5 – validated in several developing countries – was 
administered to assess the extent of problematic substance use. A 
substance-use involvement score was calculated for each substance 
used in the preceding 3 months. In the case of multiple substances, 
only the highest score was included in the total score. 
Secondary outcome: service satisfaction 
Questions were developed to assess service satisfaction and investigate 
potential barriers to treatment. Reasons for not accessing further 
treatment were explored in patients referred elsewhere for further 
treatment. 
Analysis: χ2 statistics and t-tests were used to determine loss to 
follow-up. Change in substance-use involvement scores from the pre- 
to post-test were evaluated using paired-sample t-tests. 
Results
A total of 127 substance-use patients received an intervention; 88% 
were male, 78% were single, and average age was 30 years. Black 
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District hospitals regularly experience a high incidence of substance-
use disorders, but rarely provide interventions. We describe the 
effectiveness of an intervention developed and implemented by a 
Western Cape hospital. Patients with probable substance use were 
referred to an on-site social worker for an alcohol, smoking and 
substance involvement screening test (ASSIST), a brief motivational 
intervention and referral to specialist care. At the 3-month follow-
up, the ASSIST was re-administered telephonically. An intervention 
was received by 127 patients. A significant reduction in substance 
use was reported in 92 patients who completed a 3-month follow-
up evaluation (p<0.001). Of the 60 patients referred to further care, 
half entered treatment. We conclude that, with minimal resourcing, 
it is feasible to administer a brief substance-use intervention for 
patients attending district hospitals.
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African and coloured participants comprised 47% each. The primary 
substances of abuse were methamphetamine (30%), alcohol (26%), 
cannabis (26%), mandrax (9%) and opioids (7%). Multiple substance 
use was reported by 44% of participants. Of the 127 patients, 68% 
received screening, a brief intervention and referral for specialist 
treatment for substance abuse; 32% received screening and a brief 
intervention without referral. 
Ninety-two (72%) participants completed the 3-month follow-
up interview. Attrition was not significantly associated with 
sociodemographic or substance-related variables. Substance-use 
involvement scores decreased significantly following intervention 
(pre-intervention mean 37.60±8.433, post-intervention mean 
17.02±17.19, t(72)=10.89, p<0.001). Reductions were observed in the 
use of all classes of drugs except cocaine (p=0.742, Table 1). 
Of the 92 patients who completed the follow-up, 60 (66%) were 
referred for further treatment, and 30 (50%) received additional 
services. Many participants did not provide reasons for not attending 
further care. Others reported that they did not require further 
treatment or it was a waste of time (n=8), it was too far to travel 
(n=2), they had started working (n=2) or they had moved away from 
the services (n=1). Of those that attended treatment services, 55% felt 
that the facility met their needs, 27% that the facility mostly met their 
needs, and 18% that the facility did not meet their needs.
Discussion
This evaluation yielded 3 important outcomes. Firstly, it demonstrated 
the feasibility and acceptability of introducing SBIRT for substance 
use into public hospitals in South Africa, with minimal requirements 
for additional resourcing and little burden on health professionals. 
Secondly, it provided preliminary evidence of the effectiveness of 
SBIRT in reducing illicit drug use in South Africa. Specifically, the 
intervention was successful in helping high-risk users significantly reduce 
their substance use to moderate levels. This adds to the limited body of 
knowledge supporting the effectiveness of SBIRT for illicit drug use.3,4
Thirdly, the profile of people using the SBIRT programme differed 
from those attending specialist substance-abuse treatment facilities 
in the province. While there were almost an equal proportion of 
black and coloured respondents who received substance-use services 
through the programme, black South Africans comprised only 
13% of treatment admissions in specialist substance-abuse facilities 
in 2010.6 This suggests that there are fewer barriers to accessing 
substance-abuse services co-located within the public health system 
for black South Africans compared with stand-alone drug treatment 
facilities. Consequently, introducing and scaling up the provision of 
substance-use intervention services in the public health system may 
address disparities in access to services.
These findings should be interpreted with caution; there was no 
fidelity monitoring of the intervention and data were uncontrolled. 
It remains to be shown whether SBIRT services can improve medical 
conditions exacerbated by substance use, alleviate the abuse of 
prescription drugs or lower the burden on national healthcare. 
Longitudinal studies of hospital-based SBIRT programmes are 
required for this purpose.
Nevertheless, our findings suggest that hospital-based SBIRT holds 
promise for reducing substance use and may expand access to care for 
clients who have historically faced barriers to drug treatment access. We 
recommend expanding this pilot programme to other district hospitals 
in the Western Cape. Furthermore, we recommend that the centre 
expands its services to include strategic screening for substance use 
throughout the hospital (e.g. in trauma units), rather than waiting for 
patient referral. This could facilitate earlier detection and intervention 
in substance-related problems before they become too complex to treat. 
Furthermore, the centre should invest in the ongoing monitoring of its 
services to ensure quality and effectiveness of care.
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Table 1. Pre-post differences in substance use* 
Pre Post Comparison (pre-post)
Mean SD Mean SD Mean difference p-value
Total substances (N=92) 37.60 ±8.43 17.01 ±17.19 20.41 <0.001
Alcohol (n=25) 34.52 ±8.82 10.56 ±13.58 20.71 <0.001
Dagga (n=26) 36.63 ±9.33 13.77 ±17.06 19.57 <0.001
Mandrax and dagga (n=9) 36.78 ±3.73 20.11 ±16.78 16.67 <0.030
Cocaine (n=2) 33.00 ±15.56 28.50 ±0.71 4.50 <0.742
Amphetamine (n=22) 40.18 ±6.63 23.18 ±18.75 17.00 <0.001
Opioids (n=8) 45.75 ±5.65 20.88 ±18.61 24.87 <0.010
SD = standard deviation.
*Completers only.
